{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:10:15Z","timestamp":1756375815051,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,1,27]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>We report a rare case of a term neonate presented with seizure, encephalopathy and respiratory distress, with an initial sepsis screen, serum electrolytes, blood sugar and cerebrospinal fluid (CSF) examination revealing no abnormalities. However, CT scan and MRI showed diffuse brain white matter oedema, and tandem mass spectroscopy and gas chromatography revealed elevated levels of branched chain amino acids and their ketoacids and hydroxy acids in urine. Clinical exome sequencing confirmed a mutation in the <jats:italic>BCKDHB<\/jats:italic> gene, diagnosing classical variety of maple syrup urine disease (MSUD). The baby was managed with high glucose infusion and a specialised branched-chain amino acid-free formula. This case highlights the importance of considering inborn error of metabolism (IEM) in neonates with encephalopathy and negative sepsis screens, using advanced imaging and metabolomics for timely and accurate diagnosis, prompt management to prevent ongoing encephalopathy and optimise long-term neurodevelopmental outcome. Early recognition and intervention in IEM cases can significantly impact patient outcomes, highlighting the need for a multidisciplinary approach to diagnosis and treatment.<\/jats:p>","DOI":"10.1136\/bcr-2024-263603","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T01:59:52Z","timestamp":1742954392000},"page":"e263603","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Acute encephalopathy in a neonate: a diagnostic odyssey leading to maple syrup urine disease (MSUD)"],"prefix":"10.1136","volume":"18","author":[{"given":"Neeraj","family":"Mishra","sequence":"first","affiliation":[{"name":"Neonatology, Twinke Toes Paediatric Superspeciality Hospital, Patna, Bihar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshav Kumar","family":"Pathak","sequence":"additional","affiliation":[{"name":"Neonatology, All India Institute of Medical Sciences Patna, Patna, Bihar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Prasad","sequence":"additional","affiliation":[{"name":"Radiology, Patna Medical College and Hospital, Patna, Bihar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Mishra","sequence":"additional","affiliation":[{"name":"Paediatrics and Neonatology, Twinkle Toes Paediatric Superspeciality Hospital, Patna, Bihar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"2025082802410328000_18.3.e263603.1","doi-asserted-by":"publisher","DOI":"10.1086\/323677"},{"key":"2025082802410328000_18.3.e263603.2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awp024","article-title":"Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease","volume":"132","author":"Zinnanti","year":"2009","journal-title":"Brain (Bacau)"},{"key":"2025082802410328000_18.3.e263603.3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl Clin Genet"},{"key":"2025082802410328000_18.3.e263603.4","unstructured":"Strauss KA , Puffenberger EG , Carson VJ . Maple syrup urine disease. In: Adam MP , Feldman J , Mirzaa GM , et al ., eds. GeneReviews. Seattle (WA): University of Washington, 1993. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1319\/"},{"key":"2025082802410328000_18.3.e263603.5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/clinchem\/45.10.1734","article-title":"Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease","volume":"45","author":"Schadewaldt","year":"1999","journal-title":"Clin Chem"},{"key":"2025082802410328000_18.3.e263603.6","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-007-9423-9"},{"key":"2025082802410328000_18.3.e263603.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.12.007"},{"key":"2025082802410328000_18.3.e263603.8","doi-asserted-by":"publisher","DOI":"10.1016\/0720-048X(92)90089-R"},{"key":"2025082802410328000_18.3.e263603.9","first-page":"1219","article-title":"Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants","volume":"11","author":"Brismar","year":"1990","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025082802410328000_18.3.e263603.10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11604-012-0079-2","article-title":"Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis","volume":"30","author":"Kilicarslan","year":"2012","journal-title":"Jpn J Radiol"},{"key":"2025082802410328000_18.3.e263603.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2014.05.006"},{"key":"2025082802410328000_18.3.e263603.12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7199\/ped.oncall.2014.69","article-title":"Newborn Screening in India: What are the Challenges and Pitfalls?","volume":"11","author":"Kumar","year":"2014","journal-title":"Pediatric Oncall"},{"key":"2025082802410328000_18.3.e263603.13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s12098-018-2681-5","article-title":"Status of Newborn Screening and Inborn Errors of Metabolism in India","volume":"85","author":"Kapoor","year":"2018","journal-title":"Indian J Pediatr"},{"key":"2025082802410328000_18.3.e263603.14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12098-014-1615-0","article-title":"Newborn screening: need of the hour in India","volume":"82","author":"Verma","year":"2015","journal-title":"Indian J Pediatr"},{"key":"2025082802410328000_18.3.e263603.15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12098-018-2645-9","article-title":"Newborn Screening for Congenital Hypothyroidism and Congenital Adrenal Hyperplasia","volume":"85","year":"2018","journal-title":"Indian J Pediatr"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-263603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:41:15Z","timestamp":1756374075000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-263603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,25]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bcr-2024-263603"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-263603","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}